144 related articles for article (PubMed ID: 26234362)
1. Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.
Venza M; Visalli M; Beninati C; Biondo C; Teti D; Venza I
Anticancer Agents Med Chem; 2016; 16(5):528-38. PubMed ID: 26234362
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.
Han A; Schug ZT; Aplin AE
Trends Cancer; 2021 Aug; 7(8):671-681. PubMed ID: 34127435
[TBL] [Abstract][Full Text] [Related]
4. Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma.
Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
Anticancer Agents Med Chem; 2017; 17(2):190-205. PubMed ID: 27109020
[TBL] [Abstract][Full Text] [Related]
5. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
[TBL] [Abstract][Full Text] [Related]
6. Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma.
Alexander M; Mellor JD; McArthur G; Kee D
Med J Aust; 2014 Jul; 201(1):49-53. PubMed ID: 24999899
[TBL] [Abstract][Full Text] [Related]
7. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
Wang Y; Liu M; Jin Y; Jiang S; Pan J
Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines.
Venza M; Dell'Aversana C; Visalli M; Altucci L; Teti D; Venza I
Tumori; 2014; 100(1):e4-7. PubMed ID: 24675509
[TBL] [Abstract][Full Text] [Related]
10. Role of epigenetic deregulation in hematogenous dissemination of malignant uveal melanoma.
Smolkova B; Horvathova Kajabova V; Zmetakova I; Kalinkova L; Czanner G; Markova A; Furdova A
Neoplasma; 2018 Nov; 65(6):840-854. PubMed ID: 30334454
[TBL] [Abstract][Full Text] [Related]
11. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.
Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I
Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571
[TBL] [Abstract][Full Text] [Related]
12. The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".
Strub T; Ballotti R; Bertolotto C
Theranostics; 2020; 10(4):1777-1797. PubMed ID: 32042336
[TBL] [Abstract][Full Text] [Related]
13. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
14. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
15. Role of Epigenetics in Uveal Melanoma.
Li Y; Jia R; Ge S
Int J Biol Sci; 2017; 13(4):426-433. PubMed ID: 28529451
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic insights into uveal melanoma.
Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
19. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
20. The newest treatments for uveal melanoma.
Luke JJ
Clin Adv Hematol Oncol; 2019 Sep; 17(9):490-493. PubMed ID: 31549969
[No Abstract] [Full Text] [Related]
[Next] [New Search]